Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBrigham and Women's Hospital
About this trial
Lung cancer patients undergoing upfront surgery, highly benefit from a systematic lymph node dissection in the mediastinum and in the surgical specimens. The latter is performed by the pathologist. Developing a standardized technique to dissect the lobectomy specimen has the potential of maximizing the retrieval of all N1 stations lymph nodes. The investigators believe that the adoption of such technique will improve lung cancer staging and identify a higher number of patients that qualify for adjuvant therapies.
Eligibility criteria
Qualifiers
Subjects with a lung nodule or mass who are eligible to undergo a lobectomy.
Subject without any metastasis present.
Subjects who have peripheral lung nodule location
Subjects must be 18 years of age or older.
Disqualifiers
Subjects who received preoperative chemotherapy or radiotherapy.
Subjects who have a lung nodule located in a central location. Central tumors are defined by those infiltrating the lobar airway.
Trial design
Treatments tested in this trial
- Subjects undergoing a lung specimen lymph node dissection
- Control group
Treatment groups
160 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov